132 related articles for article (PubMed ID: 21432752)
1. An open randomized pilot trial on the differential effects of aripiprazole versus risperidone on anhedonia and subjective well-being.
Liemburg E; Aleman A; Bous J; Hollander K; Knegtering H
Pharmacopsychiatry; 2011 May; 44(3):109-13. PubMed ID: 21432752
[TBL] [Abstract][Full Text] [Related]
2. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
[TBL] [Abstract][Full Text] [Related]
3. The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia.
Sato G; Yoshimura S; Yamashita H; Okamoto Y; Yamawaki S
Hiroshima J Med Sci; 2012 Dec; 61(4):75-83. PubMed ID: 23342824
[TBL] [Abstract][Full Text] [Related]
4. Effects of risperidone and aripiprazole on neurocognitive rehabilitation for schizophrenia.
Matsuda Y; Sato S; Iwata K; Furukawa S; Hatsuse N; Watanabe Y; Anzai N; Kishimoto T; Ikebuchi E
Psychiatry Clin Neurosci; 2014 Jun; 68(6):425-31. PubMed ID: 24506576
[TBL] [Abstract][Full Text] [Related]
5. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
Lu ML; Shen WW; Chen CH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
[TBL] [Abstract][Full Text] [Related]
6. Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine.
Kane JM; Meltzer HY; Carson WH; McQuade RD; Marcus RN; Sanchez R;
J Clin Psychiatry; 2007 Feb; 68(2):213-23. PubMed ID: 17335319
[TBL] [Abstract][Full Text] [Related]
7. Effect of switching to risperidone after unsuccessful treatment with aripiprazole on plasma monoamine metabolites level in the treatment of acute schizophrenia.
Miura I; Takeuchi S; Katsumi A; Kanno K; Watanabe K; Mashiko H; Niwa S
Hum Psychopharmacol; 2012 Sep; 27(5):517-20. PubMed ID: 22927115
[TBL] [Abstract][Full Text] [Related]
8. Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
Rajarethinam R; Dziuba J; Manji S; Pizzuti A; Lachover L; Keshavan M
World J Biol Psychiatry; 2009; 10(4 Pt 2):416-9. PubMed ID: 19492247
[TBL] [Abstract][Full Text] [Related]
9. Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia".
Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y
J Clin Psychopharmacol; 2011 Jun; 31(3):400-1; author reply 401. PubMed ID: 21532377
[No Abstract] [Full Text] [Related]
10. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
11. Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study.
Lee BH; Kim YK; Park SH
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):714-7. PubMed ID: 16571367
[TBL] [Abstract][Full Text] [Related]
12. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
[TBL] [Abstract][Full Text] [Related]
13. Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia.
Maat A; Cahn W; Gijsman HJ; Hovens JE; Kahn RS; Aleman A
Eur Neuropsychopharmacol; 2014 Apr; 24(4):575-84. PubMed ID: 24418213
[TBL] [Abstract][Full Text] [Related]
14. An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants.
Youssef NA; Marx CE; Bradford DW; Zinn S; Hertzberg MA; Kilts JD; Naylor JC; Butterfield MI; Strauss JL
Int Clin Psychopharmacol; 2012 Jul; 27(4):191-6. PubMed ID: 22475888
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole and haloperidol: beneficial combination antipsychotic therapy for a schizophrenic patient.
Kuo J; Hwu HG
Clin Neuropharmacol; 2008; 31(3):173-5. PubMed ID: 18520984
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study.
Mitsonis CI; Dimopoulos NP; Mitropoulos PA; Kararizou EG; Katsa AN; Tsakiris FE; Katsanou MN
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):373-7. PubMed ID: 17092620
[TBL] [Abstract][Full Text] [Related]
17. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Stip E; Tourjman V
Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
[TBL] [Abstract][Full Text] [Related]
18. Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients.
Yasui-Furukori N; Kaneda A; Sugawara N; Tomita T; Kaneko S
J Psychopharmacol; 2012 Jun; 26(6):806-12. PubMed ID: 21616975
[TBL] [Abstract][Full Text] [Related]
19. [Aripiprazole induced Parkinsonism: A case report].
Pasquier de Franclieu S; Germain C; Petitjean F
Encephale; 2009 Oct; 35(5):496-8. PubMed ID: 19853725
[TBL] [Abstract][Full Text] [Related]
20. Reversal of symptomatic hyperprolactinemia by aripiprazole.
Wahl R; Ostroff R
Am J Psychiatry; 2005 Aug; 162(8):1542-3. PubMed ID: 16055781
[No Abstract] [Full Text] [Related]
[Next] [New Search]
